SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 61.24 |
Enterprise Value ($M) | 25.38 |
Book Value ($M) | 28.74 |
Book Value / Share | 0.76 |
Price / Book | 2.13 |
NCAV ($M) | 18.37 |
NCAV / Share | 0.49 |
Price / NCAV | 3.33 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -3.51 |
Return on Assets (ROA) | -0.76 |
Return on Equity (ROE) | -0.95 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.25 |
Current Ratio | 2.25 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 44.69 |
Assets | 55.05 |
Liabilities | 26.32 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -144.07 |
Net Income | -138.43 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -119.89 |
Cash from Investing | -0.36 |
Cash from Financing | 1.67 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Baker Bros. Advisors Lp | 4.00 | -31.15 | |
13G/A | Laurion Capital Management LP | 0.00 | -100.00 | |
13G/A | State Street Corp | 1.88 | -84.94 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
183,610 | 510,558 | 35.96 | |
160,128 | 515,214 | 31.08 | |
135,333 | 1,113,531 | 12.15 | |
503,378 | 1,401,833 | 35.91 | |
74,901 | 393,469 | 19.04 | |
(click for more detail) |
Similar Companies | |
---|---|
BEAM – Beam Therapeutics Inc. | BIIB – Biogen Inc. |
BLUE – bluebird bio, Inc. | BMRN – BioMarin Pharmaceutical Inc. |
BPMC – Blueprint Medicines Corporation |
Financial data and stock pages provided by
Fintel.io